The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients
The Effects of Propofol and Dexmedetomidine Infusion on the Fluid Responsiveness in Critically Ill Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
Hypotension and bradycardia are often observed following induction of dexmedetomidine or propofol sedation.Cardiac preload decrease by sedative agents was often considered as one of main causes for this hypotension.The investigators hypothesized that hypotension after induction of sedation is caused by decrease of preload by sedative agents,and passive leg raising (PLR)test could predict this event.Dexmedetomidine or propofol infusion in patients with circulatory failure decrease cardiac preload and enhance preload-dependency and fluid responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started May 2011
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 5, 2011
CompletedFirst Posted
Study publicly available on registry
October 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJanuary 29, 2014
May 1, 2012
2.6 years
October 5, 2011
January 28, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
the area under ROC curve to predict hypotension
area under ROC curve of blood pressure changes during PLR to predict hypotension during sedation
60 min around passive leg raising test
Interventions
elevation of both legs to a 45 degrees for about 1-2 minute before sedation
Eligibility Criteria
You may qualify if:
- patients with at least one of the clinical manifestations of acute circulatory failure; patients undergoing dexmedetomidine or propofol infusion
You may not qualify if:
- deep venous thrombosis or elastic compression stocking
- an increase in the intra-abdominal pressure confirmed by clinical examination
- serious central nervous system pathology (head trauma, severe dementia, acute stroke, uncontrolled seizures)
- severe liver disease(Child-Pugh class C)
- unstable angina or acute myocardial infarction
- left ventricular ejection fraction less than 30%
- heart rate(HR) less than 50/min, heart block with second- or third degree
- systolic blood pressure (SBP) less than 90 mmHg despite 2 vasopressors infusion continuously before the begin of dexmedetomidine infusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Zhong-Da Hospital, Southeast University School of Medicine
Nanjing, 210009, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tao Yu
Nanjing Zhong-Da Hospital, Southeast University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical doctor
Study Record Dates
First Submitted
October 5, 2011
First Posted
October 6, 2011
Study Start
May 1, 2011
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
January 29, 2014
Record last verified: 2012-05